Загрузка...
Immunotherapeutic activity of a conjugate of a Toll-like receptor 7 ligand
The immunotherapeutic activity of Toll-like receptor (TLR) activators has been difficult to exploit because of side effects related to the release and systemic dispersion of proinflammatory cytokines. To overcome this barrier, we have synthesized a versatile TLR7 agonist, 4-[6-amino-8-hydroxy-2-(2-m...
Сохранить в:
| Главные авторы: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
National Academy of Sciences
2007
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1820696/ https://ncbi.nlm.nih.gov/pubmed/17360465 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0611624104 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|